Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 188

1.

Metabolic control and chronic complications during a 3-year follow-up period in a cohort of type 2 diabetic patients attended in primary care in the Community of Madrid (Spain).

Arrieta F, Piñera M, Iglesias P, Nogales P, Salinero-Fort MA, Abanades JC, Botella-Carretero JI, Calañas A, Balsa JA, Zamarrón I, Rovira A, Vázquez C; ESD2 Group..

Endocrinol Nutr. 2014 Jan;61(1):11-7. doi: 10.1016/j.endonu.2013.09.002. Epub 2013 Oct 30.

PMID:
24182687
2.

[Therapeutic approach to dyslipidemia and goal achievement in a Spanish population with type 2 diabetes without cardiovascular disease].

Pérez A, González Blanco C, Hernández-Presa MÁ, Chaves J.

Endocrinol Nutr. 2011 Jun-Jul;58(6):283-90. doi: 10.1016/j.endonu.2011.03.005. Spanish.

PMID:
21641286
3.

The impact of outpatient diabetes management on serum lipids in urban African-Americans with type 2 diabetes.

Erdman DM, Cook CB, Greenlund KJ, Giles WH, El-Kebbi I, Ryan GJ, Gallina DL, Ziemer DC, Dunbar VG, Phillips LS.

Diabetes Care. 2002 Jan;25(1):9-15.

PMID:
11772894
4.

A survey study on diabetes management and complication status in primary care setting in Thailand.

Nitiyanant W, Chetthakul T, Sang-A-kad P, Therakiatkumjorn C, Kunsuikmengrai K, Yeo JP.

J Med Assoc Thai. 2007 Jan;90(1):65-71.

PMID:
17621735
5.

[Prevalence, drug treatment and metabolic control of diabetes mellitus in primary care].

Pittrow D, Stalla GK, Zeiher AM, Silber S, März W, Pieper L, Klotsche J, Glaesmer H, Ruf G, Schneider HJ, Lehnert H, Böhler S, Koch U, Wittchen HU.

Med Klin (Munich). 2006 Aug 15;101(8):635-44. German.

PMID:
16896570
6.

Effect of a 36-month pharmaceutical care program on the coronary heart disease risk in elderly diabetic and hypertensive patients.

Neto PR, Marusic S, de Lyra Júnior DP, Pilger D, Cruciol-Souza JM, Gaeti WP, Cuman RK.

J Pharm Pharm Sci. 2011;14(2):249-63.

7.

Low incidence of cardiovascular events in Japanese patients with Type 2 diabetes in primary care settings: a prospective cohort study (JDDM 20).

Yokoyama H, Matsushima M, Kawai K, Hirao K, Oishi M, Sugimoto H, Takeda H, Minami M, Kobayashi M, Sone H; Japan Diabetes Clinical Data Management Study Group..

Diabet Med. 2011 Oct;28(10):1221-8. doi: 10.1111/j.1464-5491.2011.03347.x.

PMID:
21658121
8.

[Diabetes control in type 2 diabetic subjects treated in primary health care--how far is from life to standards?].

Fabian W, Majkowska L, Stefański A, Moleda P.

Przegl Lek. 2008;65(6):277-82. Polish.

PMID:
18853658
9.

[Diabetes control in type 2 diabetic subjects treated in primary health care].

Fabian W, Majkowska L, Moleda P, Stefański A.

Pol Arch Med Wewn. 2006 Aug;116(2):760-5. Polish.

PMID:
17424921
10.

Control of glycemia and cardiovascular risk factors in patients with type 2 diabetes in primary care in Catalonia (Spain).

Vinagre I, Mata-Cases M, Hermosilla E, Morros R, Fina F, Rosell M, Castell C, Franch-Nadal J, Bolíbar B, Mauricio D.

Diabetes Care. 2012 Apr;35(4):774-9. doi: 10.2337/dc11-1679. Epub 2012 Feb 16.

11.

Prevalence and incidence of chronic complications and mortality in a cohort of type 2 diabetic patients in Spain.

Mundet X, Pou A, Piquer N, Sanmartin MI, Tarruella M, Gimbert R, Farrus M.

Prim Care Diabetes. 2008 Sep;2(3):135-40. doi: 10.1016/j.pcd.2008.05.001. Epub 2008 Jun 27.

PMID:
18779037
12.

Renal and retinal microangiopathy after 15 years of follow-up study in a sample of Type 1 diabetes mellitus patients.

Romero P, Salvat M, Fernández J, Baget M, Martinez I.

J Diabetes Complications. 2007 Mar-Apr;21(2):93-100.

PMID:
17331857
13.

Relationships between obesity, glycemic control, and cardiovascular risk factors: a pooled analysis of cross-sectional data from Spanish patients with type 2 diabetes in the preinsulin stage.

Vázquez LA, Rodríguez Á, Salvador J, Ascaso JF, Petto H, Reviriego J.

BMC Cardiovasc Disord. 2014 Nov 1;14:153. doi: 10.1186/1471-2261-14-153.

14.

Relation of serum total sialic acid concentrations with diabetic complications and cardiovascular risk factors in Kuwaiti Type 2 diabetic patients.

Abdella N, Akanji AO, Mojiminiyi OA, Al Assoussi A, Moussa M.

Diabetes Res Clin Pract. 2000 Sep;50(1):65-72.

PMID:
10936670
15.

Clinical characteristics of type II diabetic subjects consuming high versus low carbohydrate diets in Mexico City and San Antonio, Texas.

Gonzélez C, Stern MP, Mitchell BD, Valdez RA, Haffner SM, Pérez BA.

Diabetes Care. 1994 May;17(5):397-404.

PMID:
8062606
16.

Risk association of HbA1c variability with chronic kidney disease and cardiovascular disease in type 2 diabetes: prospective analysis of the Hong Kong Diabetes Registry.

Luk AO, Ma RC, Lau ES, Yang X, Lau WW, Yu LW, Chow FC, Chan JC, So WY.

Diabetes Metab Res Rev. 2013 Jul;29(5):384-90. doi: 10.1002/dmrr.2404.

PMID:
23463747
17.
18.

[Screening for hyperlipidemia in cardiovascular high-risk patients in austrian diabetes ambulances].

Brath H, Wascher TC, Kästenbauer T, Toplak H.

MMW Fortschr Med. 2012 Jun 28;154 Suppl 2:41-7. German.

PMID:
23424754
19.

Glycemic control and diabetic dyslipidemia in adolescents with type 2 diabetes.

Le PT, Huisingh CE, Ashraf AP.

Endocr Pract. 2013 Nov-Dec;19(6):972-9. doi: 10.4158/EP13016.OR.

PMID:
23807519

Supplemental Content

Support Center